视网母细胞瘤 - 一个全面的审查,更新和最近的进展
Adwaita Nag1, Vikas Khetan2,3
1Ocular Oncology Service, Department of Ophthalmology and Vision Sciences, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Indian journal of ophthalmology
|May 28, 2024
概括
视网母细胞瘤是一种常见的儿童眼癌,是由RB1基因突变驱动的. 现代治疗侧重于使用化疗和焦点疗法挽救眼睛,改善结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
背景情况:
- 视网母细胞瘤是最常见的儿科眼部恶性瘤.
- 它是由RB1基因突变或MYCN放大引起的,单边或双边呈现.
- 发展中国家面临的挑战是高患病率,晚期诊断和有限的医疗保健接入,导致更差的结果.
研究的目的:
- 审查目前对视网膜母细胞瘤的理解和管理.
- 突出治疗策略的演变,从激进的方法到拯救眼睛的方法.
- 讨论视网膜母细胞瘤研究和治疗的未来方向.
主要方法:
- 关于视网膜母细胞瘤遗传学,诊断和治疗的当前文献的综述.
- 分析治疗方式,包括化疗,焦点疗法和遗传咨询.
- 探索新兴的诊断和治疗技术.
主要成果:
- 治疗已经转向多式疗法,将化疗 (动脉内,静脉内,静脉内) 与焦点疗法 (TTT,冷疗法,激光) 结合起来.
- 在可能的情况下,眼睛的挽救优先于除核.
- 基因检测和查对于遗传形式和家族成员至关重要.
结论:
- 多模式治疗是视网膜母细胞瘤的标准,提高了眼睛的挽救率.
- 晚期和转移性视网膜母细胞瘤仍然呈现出不良的预后.
- 针对性治疗,液体活检和产前诊断的未来研究有望改善患者的治疗结果.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


